SCH51866   Click here for help

GtoPdb Ligand ID: 5270

Synonyms: SCH 51866 | SCH-51866
Compound class: Synthetic organic
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 67.97
Molecular weight 389.15
XLogP 5.94
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Cn1c(=O)c2[nH]c(nc2n2c1=NC1C2CCC1)Cc1ccc(cc1)C(F)(F)F
Isomeric SMILES Cn1c(=O)c2[nH]c(nc2n2c1=N[C@H]1[C@@H]2CCC1)Cc1ccc(cc1)C(F)(F)F
InChI InChI=1S/C19H18F3N5O/c1-26-17(28)15-16(27-13-4-2-3-12(13)23-18(26)27)25-14(24-15)9-10-5-7-11(8-6-10)19(20,21)22/h5-8,12-13H,2-4,9H2,1H3,(H,24,25)/t12-,13+/m1/s1
InChI Key JOSMPBVYYKRYLG-OLZOCXBDSA-N
References
1. Fisher DA, Smith JF, Pillar JS, St Denis SH, Cheng JB. (1998)
Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase.
J Biol Chem, 273 (25): 15559-64. [PMID:9624146]
2. Sasaki T, Kotera J, Yuasa K, Omori K. (2000)
Identification of human PDE7B, a cAMP-specific phosphodiesterase.
Biochem Biophys Res Commun, 271 (3): 575-83. [PMID:10814504]
3. Vemulapalli S, Watkins RW, Chintala M, Davis H, Ahn HS, Fawzi A, Tulshian D, Chiu P, Chatterjee M, Lin CC et al.. (1996)
Antiplatelet and antiproliferative effects of SCH 51866, a novel type 1 and type 5 phosphodiesterase inhibitor.
J Cardiovasc Pharmacol, 28 (6): 862-9. [PMID:8961086]